Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jiongtao Zhou"'
Autor:
Ruixin Li, Jiongtao Zhou, Zhengyuan Liu, Xi Chen, Qiqiang Long, Yan Yang, Shengyun Lin, Jinsong Jia, Guangsheng He, JianYong Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Addition of eltrombopag (E-PAG) to intensive immunosuppressive therapy (IST) contributes to restoring hematopoiesis in patients with severe aplastic anemia (SAA). Used at relatively low doses in the East Asian population, the efficacies of E-PAG and
Externí odkaz:
https://doaj.org/article/7cd332d9dca34046905562ee3ea590e3
Autor:
Jinsong Jia, Qiqiang Long, Xiaoqing Liu, Lang Cheng, Jiongtao Zhou, Xi Chen, Jianyong Li, Shengyun Lin, Zhengyuan Liu, Yan Yang, Yuanyuan Jin, Ruixin Li, Guangsheng He
Publikováno v:
Blood. 138:1115-1115
Prospective trials showed the clinical efficacy of eltrombopag in refractory/relapsed aplastic anemia (AA), with up to 40% hematologic improvement [1]. Moreover, eltrombopag was combined with frontline immunosupressive therapy (IST) consisited of ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db92cdc8d817eb53b383ebc397d253d
https://doi.org/10.1182/blood-2021-152756
https://doi.org/10.1182/blood-2021-152756
Autor:
Lang Cheng, Qiqiang Long, Ruixin Li, Jianyong Li, Zhengyuan Liu, Xiaoqing Liu, Guangsheng He, Jiongtao Zhou
Publikováno v:
Blood. 138:1120-1120
Background Large granular lymphocyte leukemia associated pure red cell aplasia (LGLL-PRCA) accounts for a significant portion of secondary PRCA. Cyclosporine (CsA) and cyclophosphamide (CTX) are the main immunosuppressive agents used in treating LGLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::052fab006e1f52d716dd52266c985c0e
https://doi.org/10.1182/blood-2021-154248
https://doi.org/10.1182/blood-2021-154248